GNVR · Genvor Inc
$0.62
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern. Management's plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$22.39M
Shares
36.41M
Volume · Oct 19
100
Avg daily vol (3M)
3763
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.62
Open$0.62
Day$0.62–0.62
52W close$0.20–2.00
Avg vol 30d4K
Short int2K · 0.0% float · 1.0d
Short vol100%
DataDec 2023–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$0
Trailing 12 months
Net income (TTM)
−$3.45M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$17,231
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+31.3%
Year over year · more shares
Price change (1Y)
-38.5%
Trailing year
Short interest
0.0%
Latest settlement · 1.0 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 17.3 · elevated
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 50-day avg
+5%
above
RSI (14)
47
neutral
MACD trend
Negative
52-week position
23%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−12%
trailing
6-month return
−68%
trailing
YTD return
−39%
this year
Relative strength
−76%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +762.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
37
low risk · 0–100
Fundamentals
EPS growth
−47%
Y/Y
Balance sheet
$17.2K
net cash
Quant / Vol
risk profile
Volatility
297510%
annualized · 1-yr
Max drawdown
−100%
past year
ATR
31.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 50-day avg
+5%
Bullish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
23%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross)
No cross
50/200-day averages unavailable
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.00% of float · ▲ +762.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0
Now $1 · 23%
Range high $2
vs 50-day avg +5%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GNVR
this stock
Genvor Inc
|
$22.39M | -38.5% | — | — | 0.0% |
|
NTR
Nutrien Ltd.
|
$33.14B | +12.5% | — | — | 2.7% |
|
CF
CF Industries Holdings, Inc.
|
$17.85B | +52.5% | +19.3% | 8.8 | 6.6% |
|
YARIY
Yara International ASA
|
$10.87B | +6.8% | — | — | 0.0% |
|
CTVA
Corteva, Inc.
|
$8.61B | -80.8% | +2.9% | 8.4 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionShort & Settlement
Financials
Filings
SEC Filings
Latest
8-K
- Filed
- Oct 19, 2026
- This year
- 9
Genvor Incorporated issued promissory notes to directors Dr. Jesse Jaynes and Dr. Clayton Yates, receiving $20,000 and $10,000 on October 8, 2026. Each note carries a 2% original issue discount and 15% annual interest, due April 8, 2027.
ViewEarnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GNVR | -19.4% | -12.1% | -68.3% | -19.4% | -38.5% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -17.9% | -11.2% | -76.0% | -19.9% | -50.9% |